2m 2m 2m 2m 2m 2m 2m
SUTRO BIOPHARMA (STRO)
NASDAQ
$10.29-$0.50 (-4.68%)
Price as of Oct 22, 2026 6:30 PM EDT- $178.9MMarket Cap
- -6.98%1-Year Change
- BiotechnologyIndustry
SUTRO BIOPHARMA (STRO)
$10.29-$0.50 (-4.68%)
STRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.79 | ||
Change | -$0.75 (-6.50%) | ||
Open | $11.62 | ||
High | $11.80 | ||
Low | $10.75 | ||
Previous Close | $11.54 | ||
Volume | 439,854 | ||
30-Day Average Volume | 296,717 | ||
1-Week Change | 2.57% | ||
1-Month Change | -34.01% | ||
1-Year Change | -6.98% | ||
3-Year Change | -66.18% | ||
5-Year Change | -94.25% | ||
Fundamentals | |||
Shares Outstanding | 16.6M | ||
Total Assets | $194.5M | ||
Market Cap | $178.9M | ||
Enterprise Value | $124.6M | ||
Period: QTR TTM FY | |||
Revenue | $9.8M | ||
Net Income | -$38.5M | ||
Free Cash Flow | -$38.3M | ||
EBIT | -$38.5M | ||
EBITDA | -$37.3M | ||
Net Working Capital | $122.7M | ||
EPS | -$2.33 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -2 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/03/2025 | ||
Earnings & Revenue